The global conversation around muscle mass is undergoing a significant transformation. Once primarily the domain of bodybuilders and elite athletes, muscle tissue is now recognized as a critical biomarker for metabolic health, longevity, and overall physiological resilience. Recent developments in sports nutrition, geriatric medicine, and molecular biology are converging to reshape how researchers, clinicians, and consumers approach muscle maintenance and growth.

Industry Dynamics: The Shift from Aesthetics to Longevity

The global muscle health and sports nutrition market, valued at approximately USD 44 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 8.2% through 2030, according to a report by Grand View Research. This expansion is driven not only by traditional gym-goers but also by an aging population increasingly aware of sarcopenia—the age-related loss of muscle mass and function.

“The narrative has shifted dramatically in the last five years,” says Dr. Elena Marchetti, a gerontologist at the University of Milan. “We are no longer just talking about muscle mass for performance or appearance. We are talking about it as a vital organ system that influences glucose metabolism, immune function, and even cognitive health.”

This shift is reflected in product development. Major sports nutrition brands such as Optimum Nutrition and Myprotein have expanded their portfolios to include formulations targeting older adults, with lower stimulant content and added joint-support ingredients. Meanwhile, companies like Nestlé Health Science have acquired specialized brands such as Vital Proteins to tap into the growing collagen-for-muscle niche, despite ongoing debate about collagen’s direct impact on muscle protein synthesis.

Scientific Breakthroughs: Beyond Protein Timing

The classic model of muscle hypertrophy—consume sufficient protein, perform resistance training, and rest—is being refined by new insights into molecular signaling pathways. A key area of focus is the mTORC1 pathway, which governs cellular growth. Recent research published inCell Metabolism(2024) suggests that intermittent activation of mTORC1, rather than constant stimulation, may yield better long-term muscle retention while reducing the risk of metabolic dysregulation.

“We are learning that the ‘more is better’ approach to protein intake may not apply to everyone,” explains Dr. James Kwon, a researcher at the University of Texas Southwestern Medical Center. “For certain populations, particularly older adults with reduced anabolic sensitivity, the quality of protein and the timing of leucine-rich meals may be more important than total daily intake.”

Another emerging area is the role of myokines—signaling molecules released by contracting muscles. A 2024 study from the Karolinska Institute found that regular resistance training increases the release of myokines such as irisin and interleukin-6, which appear to mediate cross-talk between muscle, adipose tissue, and the brain. This has led to growing interest in “exercise mimetics”: compounds that could stimulate similar signaling pathways in individuals unable to exercise.

Technological Innovations: Wearables and AI-Driven Training

The integration of technology into muscle mass management is accelerating. Companies like Smart Scales and Smart Scales have introduced body composition scales that use bioelectrical impedance analysis (BIA) to estimate lean mass, though accuracy remains a concern. More advanced tools, such as DEXA (dual-energy X-ray absorptiometry) scanning, are becoming increasingly accessible through mobile clinics and gym partnerships.

Artificial intelligence is also entering the field. Startups like TrainAI and FitGenie now offer personalized resistance training programs based on user data, including historical progress, recovery metrics, and even genetic markers related to muscle fiber type. “We are moving toward a future where your workout is dynamically adjusted in real time based on your muscle fatigue and hormonal state,” says Sarah Lin, CEO of TrainAI. “This has the potential to reduce injury risk and maximize hypertrophy efficiency.”

Regulatory and Safety Considerations

As the market expands, regulatory scrutiny is intensifying. The U.S. Food and Drug Administration (FDA) has issued warning letters to several supplement companies for making unsubstantiated claims about muscle-building effects, particularly those involving “natural anabolics” like ecdysteroids and beta-ecdysone. The European Food Safety Authority (EFSA) has similarly tightened guidelines for protein and amino acid health claims.

“Many consumers are looking for shortcuts, but the evidence base for most ‘muscle-building’ supplements beyond whey protein, creatine, and essential amino acids is weak,” cautions Dr. Marchetti. “We need to be careful that the trend toward muscle mass optimization does not lead to unsafe practices, such as excessive protein intake that may strain kidney function in predisposed individuals.”

Demographic Shifts: Women and Older Adults Leading Growth

One of the most notable trends is the rising participation of women in resistance training. According to the International Health, Racquet & Sportsclub Association (IHRSA), the number of women strength training at least twice per week increased by 37% between 2020 and 2024. This demographic shift is influencing product formulation, with brands launching lower-calorie protein powders and pre-workouts tailored to female hormonal cycles.

At the same time, the over-65 population is emerging as a key target for muscle mass interventions. A 2023 meta-analysis in theBritish Journal of Sports Medicinefound that even modest increases in lean mass—as little as 1.5 kg—were associated with a 20% reduction in all-cause mortality in older adults. Public health campaigns in Japan and Scandinavia now include specific guidelines for protein intake and resistance training frequency for seniors.

Challenges and Unanswered Questions

Despite the progress, significant gaps remain. The long-term effects of high-protein diets on kidney and bone health are still debated. The role of gut microbiome in amino acid absorption and muscle protein synthesis is only beginning to be understood. And the question of how to maintain muscle mass during caloric restriction—critical for obesity management—remains a clinical challenge.

“We have excellent data on how to build muscle in young, healthy males,” says Dr. Kwon. “But we need more research on women, older adults, and individuals with chronic conditions like diabetes or cancer cachexia. Muscle mass is not one-size-fits-all.”

Looking Ahead

The next frontier in muscle mass research may lie in combination therapies. Early-stage trials are exploring the synergistic effects of resistance training with low-dose testosterone replacement, selective androgen receptor modulators (SARMs), and even novel compounds like bimagrumab, an activin receptor inhibitor initially developed for muscle wasting diseases. However, experts caution that these interventions remain experimental and carry potential risks.

“The safest and most effective way to build muscle is still consistent resistance training and adequate protein intake,” Dr. Marchetti concludes. “But we are entering an era where we can personalize that approach with unprecedented precision. The challenge is to balance innovation with evidence-based practice.”

As the science of muscle mass continues to evolve, one thing is clear: lean tissue is no longer just a measure of strength. It is a central pillar of human health, spanning metabolism, immunity, and longevity. The industry’s ability to deliver safe, effective, and accessible solutions will determine how well this growing awareness translates into real-world outcomes.